These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8102187)

  • 1. [The effect of neuroleptics on human brain estimated by SPECT and PET].
    Hatazawa J
    Kaku Igaku; 1993 Jun; 30(6):687-92. PubMed ID: 8102187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Receptor occupancy and antipsychotic drug action measured by PET and SPECT].
    Okubo Y; Suhara T
    Seishin Shinkeigaku Zasshi; 2001; 103(4):329-40. PubMed ID: 11392846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 receptor imaging and neuroleptic drug response.
    Heinz A; Knable MB; Weinberger DR
    J Clin Psychiatry; 1996; 57 Suppl 11():84-8; discussion 89-93. PubMed ID: 8941175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.
    Seibyl JP; Zea-Ponce Y; Brenner L; Baldwin RM; Krystal JH; Offord SJ; Mochoviak S; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Jan; 37(1):11-5. PubMed ID: 8543979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of anti-psychotic agents on brain glucose metabolism and regional cerebral circulation in patients with schizophrenia-- study by functional brain imaging of SPECT and PET].
    Jibiki I
    Seishin Shinkeigaku Zasshi; 2002; 104(2):144-51. PubMed ID: 11985069
    [No Abstract]   [Full Text] [Related]  

  • 6. Delusional infestation: neural correlates and antipsychotic therapy investigated by multimodal neuroimaging.
    Freudenmann RW; Kölle M; Huwe A; Luster M; Reske SN; Huber M; Lepping P; Wolf RC; Schönfeldt-Lecuona C
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1215-22. PubMed ID: 20600460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of scatter correction on D2 receptor occupancy measurements using 123I-IBZM SPECT: comparison to 11C-Raclopride PET.
    Bullich S; Cot A; Gallego J; Gunn RN; Suárez M; Pavía J; Ros D; Laruelle M; Catafau AM
    Neuroimage; 2010 May; 50(4):1511-8. PubMed ID: 20083205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of positron emission tomography research for the investigation of the actions of antipsychotic drugs.
    List SJ; Cleghorn JM
    Br J Psychiatry Suppl; 1993 Dec; (22):25-30. PubMed ID: 7906522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of receptors in clinical neurosciences.
    Korf J
    Acta Neurol Belg; 1997 Sep; 97(3):200-5. PubMed ID: 9345594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nuclear medicine for evaluation of brain function].
    Yonekura Y
    Kaku Igaku; 1995 Dec; 32(12):1375-9. PubMed ID: 8587221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo neuropharmacology of schizophrenia.
    Bigliani V; Pilowsky LS
    Br J Psychiatry Suppl; 1999; (38):23-33. PubMed ID: 10884897
    [No Abstract]   [Full Text] [Related]  

  • 12. [The next generation of "atypical" antipsychotics: the role of positron emission tomography].
    Gründer G; Wong DF
    Fortschr Neurol Psychiatr; 2003 Aug; 71(8):415-20. PubMed ID: 12910447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
    Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L
    Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
    Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating dopamine D₂ receptor occupancy for doses of 8 antipsychotics: a meta-analysis.
    Lako IM; van den Heuvel ER; Knegtering H; Bruggeman R; Taxis K
    J Clin Psychopharmacol; 2013 Oct; 33(5):675-81. PubMed ID: 23948784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring receptor occupancy with PET.
    Waarde Av
    Curr Pharm Des; 2000 Nov; 6(16):1593-610. PubMed ID: 10974155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.
    Mamo D; Kapur S; Shammi CM; Papatheodorou G; Mann S; Therrien F; Remington G
    Am J Psychiatry; 2004 May; 161(5):818-25. PubMed ID: 15121646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serotonin-2A receptor occupancy with 123I-5-I-R91150 and single-photon emission tomography before and after low-dose pipamperone administration in the canine brain.
    Peremans K; De Spiegeleer B; Buntinx E; Dobbeleir A; Vermeire S; Vandermeulen E; De Vos F; Megens A; Eersels J; Audenaert K
    Nucl Med Commun; 2008 Aug; 29(8):724-9. PubMed ID: 18753826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
    Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ
    Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single photon emission computed tomography (SPECT) measures of brain function in schizophrenia.
    Gordon E; Barry RJ; Anderson J; Fawdry R; Yong C; Grunewald S; Meares RA
    Aust N Z J Psychiatry; 1994 Sep; 28(3):446-52. PubMed ID: 7893239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.